ArticleDiabetology & metabolic syndrome2025

Understanding the risk of diabetic retinopathy from glucagon-like peptide-1 receptor agonists: a Mendelian randomization study and systematic review of European populations.

Baixuan Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.